Completed × Lymphoma, Non-Hodgkin × Lenalidomide × Clear all
NCT02213913 2026-03-11

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

University of Chicago

Phase 1/2 Completed
55 enrolled 17 charts
NCT01254578 2017-09-25

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

National Cancer Institute (NCI)

Phase 1 Completed
17 enrolled
NCT00031941 2012-03-15

CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy

National Institutes of Health Clinical Center (CC)

Phase 1 Completed